×
Cryo-Cell EBIT 2010-2024 | CCEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cryo-Cell ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Cryo-Cell EBIT 2010-2024 | CCEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cryo-Cell ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$95.8B
Cencora (COR)
$49B
DiDi Global (DIDIY)
$23.3B
ICON (ICLR)
$17.5B
Natera (NTRA)
$16.7B
Viatris (VTRS)
$15.4B
Avantor (AVTR)
$14.8B
Revvity (RVTY)
$14.6B
BioMerieux (BMXMF)
$12.9B
CochLear (CHEOY)
$12.7B
Solventum (SOLV)
$12.2B
Medpace Holdings (MEDP)
$11.2B
Charles River Laboratories (CRL)
$11B
Doximity (DOCS)
$10.8B
HealthEquity (HQY)
$8.7B
Sonic Healthcare (SKHHY)
$8.5B
Bausch + Lomb (BLCO)
$6.9B
Life Times (LTH)
$5B
Sotera Health (SHC)
$4.4B
Organon (OGN)
$4B
Surgery Partners (SGRY)
$3.8B
BrightSpring Health Services (BTSG)
$3.4B
PACS (PACS)
$3.1B
Concentras Parent (CON)
$2.6B
Alignment Healthcare (ALHC)
$2.5B
Ardent Health Partners (ARDT)
$2.4B
Premier (PINC)
$2.3B
GeneDx Holdings (WGS)
$2.1B
Ryman Healthcare (RYHTY)
$2B
GoodRx Holdings (GDRX)
$1.8B